Literature DB >> 23055855

Caffeine Therapeutic Drug Monitoring Is Necessary and Cost-effective.

Peter Gal1.   

Abstract

Entities:  

Keywords:  caffeine; pharmacoeconomics; therapeutic drug monitoring

Year:  2007        PMID： 23055855      PMCID： PMC3462085          DOI： 10.5863/1551-6776-12.4.212

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN： 1551-6776


× No keyword cloud information.
  8 in total

1.  Concerns about the Food and Drug Administration guidelines for neonatal theophylline dosing.

Authors:  P Gal; J T Gilman
Journal:  Ther Drug Monit       Date:  1986       Impact factor: 3.681

Review 2.  Therapeutic drug monitoring in neonates: problems and issues.

Authors:  P Gal
Journal:  Drug Intell Clin Pharm       Date:  1988-04

3.  Summary proceedings from the apnea-of-prematurity group.

Authors:  Neil N Finer; Rosemary Higgins; John Kattwinkel; Richard J Martin
Journal:  Pediatrics       Date:  2006-03       Impact factor: 7.124

Review 4.  Drug concentration monitoring. An approach to rational use.

Authors:  G R Brown; M Miyata; J P McCormack
Journal:  Clin Pharmacokinet       Date:  1993-03       Impact factor: 6.447

5.  Undetected episodes of prolonged apnea and severe bradycardia in preterm infants.

Authors:  D P Southall; G A Levitt; J M Richards; R A Jones; C Kong; P A Farndon; J R Alexander; A J Wilson
Journal:  Pediatrics       Date:  1983-10       Impact factor: 7.124

6.  Therapeutic drug monitoring for caffeine in preterm neonates: an unnecessary exercise?

Authors:  Girija Natarajan; Mirjana-Lulic Botica; Ronald Thomas; Jacob V Aranda
Journal:  Pediatrics       Date:  2007-05       Impact factor: 7.124

7.  Neonatal apnea: diagnosis by nurse versus computer.

Authors:  S C Muttitt; N N Finer; A J Tierney; J Rossmann
Journal:  Pediatrics       Date:  1988-11       Impact factor: 7.124

Review 8.  Caffeine citrate: a review of its use in apnoea of prematurity.

Authors:  A M Comer; C M Perry; D P Figgitt
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.930
  8 in total
  6 in total

1.  Optimum Use of Therapeutic Drug Monitoring and Pharmacokinetics-Pharmacodynamics in the NICU.

Authors:  Peter Gal
Journal:  J Pediatr Pharmacol Ther       Date:  2009-04

2.  Caffeine ameliorates hyperoxia-induced lung injury by protecting GCH1 function in neonatal rat pups.

Authors:  Xigang Jing; Yi-Wen Huang; Jason Jarzembowski; Yang Shi; Girija G Konduri; Ru-Jeng Teng
Journal:  Pediatr Res       Date:  2017-05-24       Impact factor: 3.756

Review 3.  Utility, promise, and limitations of liquid chromatography-mass spectrometry-based therapeutic drug monitoring in precision medicine.

Authors:  Vanessa P Gaspar; Sahar Ibrahim; René P Zahedi; Christoph H Borchers
Journal:  J Mass Spectrom       Date:  2021-11-04       Impact factor: 1.982

4.  Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonates.

Authors:  Tian Yu; Alfred H Balch; Robert M Ward; E Kent Korgenski; Catherine M T Sherwin
Journal:  BMC Pharmacol Toxicol       Date:  2016-06-07       Impact factor: 2.483

Review 5.  Caffeine in preterm infants: where are we in 2020?

Authors:  Laura Moschino; Sanja Zivanovic; Caroline Hartley; Daniele Trevisanuto; Eugenio Baraldi; Charles Christoph Roehr
Journal:  ERJ Open Res       Date:  2020-03-02

Review 6.  Towards wearable and implantable continuous drug monitoring: A review.

Authors:  Sumin Bian; Bowen Zhu; Guoguang Rong; Mohamad Sawan
Journal:  J Pharm Anal       Date:  2020-08-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.